Commercialization of automated mobile device for accurate comprehensive refraction

NIH RePORTER · NIH · R44 · $681,852 · view on reporter.nih.gov ↗

Abstract

Summary The goal of this CRP SBIR application is to commercialize QuickSee Plus that was researched and developed during SBIR Phase 2 work. QuickSee Plus, will be a unique tool for eye care professionals that enables comprehensive refraction (objective and subjective) in a single, portable package. It will provide tremendous value for eye care professionals as it improves their efficiency within the clinic and extends their reach outside the clinic, thereby, greater accessibility to refractive eye care for health disparity populations

Key facts

NIH application ID
10138790
Project number
2R44EY025452-04
Recipient
PLENOPTIKA, INC.
Principal Investigator
Gary Yiu-Kin Chu
Activity code
R44
Funding institute
NIH
Fiscal year
2021
Award amount
$681,852
Award type
2
Project period
2015-09-30 → 2023-02-28